Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?

E-ISSN： 1873-4294|16|19|2115-2124

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.19, 2016-08, pp. : 2115-2124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccines - The Promise of More Effective Less Toxic, Cancer Therapy

Pharmaceutical Innovation, Vol. 10, Iss. 6, 2001-10 ,pp. : 2-50

Adis International

Access to resources Recommend Favorite

Co-Treatment With Copper Compounds Dramatically Decreases Toxicities Observed With Cisplatin Cancer Therapy And The Anticancer Efficacy Of Some Copper Chelates Supports The Conclusion That Copper Chelate Therapy May Be Markedly More Effective And Less Toxic Than Cisplatin Therapy

Current Medicinal Chemistry, Vol. 14, Iss. 14, 2007-06 ,pp. : 1499-1503

Bentham Science Publishers

Access to resources Recommend Favorite

HIF Inhibitors: New Hope for Cancer Therapy

Letters in Drug Design & Discovery, Vol. 12, Iss. 9, 2015-01 ,pp. : 736-753

Bentham Science Publishers

Access to resources Recommend Favorite

Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis

Current Drug Targets, Vol. 14, Iss. 14, 2013-01 ,pp. : 1675-1682

Bentham Science Publishers

Access to resources Recommend Favorite

Less Pain, More Gain: Buprenorphine-Naloxone and Patient Retention in Treatment

By Renzelli Cara M. Capretto Neil A.

Journal of Addictive Diseases, Vol. 25, Iss. 3, 2006-08 ,pp. : 97-104

Haworth Press

Access to resources Recommend Favorite